Product Details

Taro-Budesonide

Budesonide
0.5 mg/mL
Suspension for Inhalation


DIN/PIN/NPN

02494280

Manufacturer

Taro Pharmaceuticals Inc.

Formulary Listing Date

2021-07-30  

Unit Price

0.4559

Amount MOH Pays

0.4559

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

R03BA02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02465957 Teva-Budesonide 0.4559 0.4559
02494280 Taro-Budesonide 0.4559 0.4559
01978926 Pulmicort Nebuamp 1.0622 0.4559
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
Note: For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.
260 Indefinite

Children aged 6 years or less;

261 Indefinite

Patients who have a tracheostomy;

262 Indefinite

Patients with cystic fibrosis in whom nebulizer therapy is indicated;

263 Indefinite

Patients with severe mental or physical disabilities;

264 Indefinite

Patients who have previously used nebulizer therapy within the last 12-month period.

 

EAP Criteria

NO

Product Monograph

View Monograph